IJMS, Vol. 25, Pages 6628: A20 in Kidney Transplantation and Autoimmunity

4 weeks ago 13

IJMS, Vol. 25, Pages 6628: A20 in Kidney Transplantation and Autoimmunity

International Journal of Molecular Sciences doi: 10.3390/ijms25126628

Authors: Andreas Kommer Myriam Meineck Paul Classen Julia Weinmann-Menke

A20, the central inhibitor of NFκB, has multiple anti-inflammatory properties, making it an interesting target in kidney autoimmune disease and transplant biology. It has been shown to be able to inhibit inflammatory functions in macrophages, dendritic cells, T cells, and B cells in various ways, leading to less tissue damage and better graft outcomes. In this review, we will discuss the current literature regarding A20 in kidney transplantation and autoimmunity. Future investigations on animal models and in existing immunosuppressive therapies are needed to establish A20 as a therapeutic target in kidney transplantation and autoimmunity. Cell-based therapies, modified viruses or RNA-based therapies could provide a way for A20 to be utilized as a promising mediator of inflammation and tissue damage.

Read Entire Article